查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲 PCR 技術市場預測至 2030 年 - 區域分析 - 按技術、產品、應用和最終用戶
市場調查報告書
商品編碼
1562195

歐洲 PCR 技術市場預測至 2030 年 - 區域分析 - 按技術、產品、應用和最終用戶

Europe PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 147 Pages | 訂單完成後即時交付

價格

歐洲PCR技術市場預計將從2022年的38.8013億美元成長到2030年的71.7373億美元。

新興國家擴大採用 PCR 技術推動歐洲 PCR 技術市場

即時 (POC) 檢測透過擴大其範圍和應用，為 PCR 技術市場帶來了重大機會。 PCR 技術以其準確性和靈敏度而聞名，由於能夠在照護端或附近提供快速可靠的結果，因此擴大應用於 POC 測試。隨著 POC 測試在診所、急診室和分散設施等醫療機構中變得越來越普遍，針對 POC 應用客製化的 PCR 平台和檢測的需求預計將會增加。

PCR 的優勢，包括能夠以高特異性和敏感性檢測傳染病，使其非常適合 POC 檢測，特別是在需要快速診斷和治療決策的情況下。此外，PCR 系統的小型化和自動化進一步使其能夠整合到 POC 設置中，促進現場測試並改善患者護理結果。隨著醫療保健提供者越來越認知到 POC PCR 檢測在增強診斷能力和患者管理方面的價值，POC PCR 技術市場有望實現成長和創新。

歐洲 PCR 技術市場概況

歐洲 PCR 技術市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。政府和私人組織為高級研究提供的資金、人工 DNA 合成創新技術的推出以及基於新技術的應用的各種研究的增加推動了歐洲 PCR 技術市場的成長。此外，各國政府透過對研發和新生物技術新創企業的激勵措施和免稅來鼓勵創新，預計將有利於歐洲 PCR 技術市場在預測期內的成長。德國是歐洲和全球最大的生物技術中心之一，擁有著名的生物技術企業、高科技研究實驗室以及用於在新科學技術領域開展研發活動的大量資金。該國擁有的生物技術公司比其他歐洲國家都多。德國正在進行的尖端和高品質研究為已經建立的 PCR 技術市場創造了利潤豐厚的機會。該國的個人研究人員和學術大學與國際實驗室和機構合作，創造突破性創新。資金和補助金的增加以及合成生物學在各個應用領域的使用不斷增加是有利於德國 PCR 技術市場成長的主要因素。德國政府認為新創企業的組成是該國生物技術產業發展的重要組成部分。例如，BIO Deutschland 是德國生物技術產業的產業協會，總部位於柏林，擁有 330 多名會員，致力於促進和支持該產業的發展，幫助其發展成為一個強大的經濟實體。同樣，泛歐交易所是另一個認知並利用生物技術產業當前勢頭的組織。因此，它透過創造就業機會、籌集資金和投資以及以各種其他方式支持公司來幫助新創公司。

歐洲 PCR 技術市場收入及 2030 年預測（百萬美元）

歐洲 PCR 技術市場細分

歐洲 PCR 技術市場分為技術、產品、應用、最終用戶和國家。

依技術，歐洲PCR技術市場分為即時PCR、常規PCR、逆轉錄、數位PCR、多重RTPCR、熱啟動PCR等。 2022 年，即時 PCR 領域在歐洲 PCR 技術市場中佔據最大佔有率。

在產品方面，歐洲 PCR 技術市場分為試劑和耗材、儀器以及軟體和服務。到2022年，試劑和耗材細分市場在歐洲PCR技術市場中佔據最大佔有率。此外，西林瓶尺寸分為0.2ml至2ml、0.1ml至0.3ml、2ml至5ml等西林瓶。此外，儀器部分分為桌上型 PCR 和攜帶式熱循環儀/PCR。

依應用分類，歐洲 PCR 技術市場分為基因表現分析、基因定序、基因分型、核酸合成、標準驗證、照護端診斷應用、環境應用等。 2022 年，基因表現分析領域佔據歐洲 PCR 技術市場的最大佔有率。

根據最終用戶，歐洲 PCR 技術市場分為醫院和診斷中心、製藥和生物技術公司、學術機構和研究實驗室等。 2022 年，醫院和診斷中心細分市場佔據歐洲 PCR 技術市場的最大佔有率。

依國家/地區分類，歐洲 PCR 技術市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲 PCR 技術市場佔據主導地位。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc 和 Ellume Ltd 等在歐洲PCR技術市場營運的領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲 PCR 技術市場 - 主要產業動態

  • PCR 技術市場 - 主要產業動態
  • 市場促進因素
    • 遺傳性疾病和傳染病的盛行率不斷上升
    • PCR 技術的投資和資金供應激增
  • 市場限制
    • PCR 系統的高成本和替代檢測的可用性
  • 市場機會
    • POC 測試需求不斷增加
  • 未來趨勢
    • PCR 技術的進步
  • 促進因素和限制的影響：

第 5 章：PCR 技術市場 - 歐洲市場分析

  • PCR 技術市場收入，2020 - 2030

第 6 章：歐洲 PCR 技術市場分析 - 按技術

  • 概述
  • 即時螢光定量PCR
  • 常規PCR
  • 逆轉錄聚合酶連鎖反應
  • 數位PCR
  • 多重逆轉錄聚合酶連鎖反應
  • 熱啟動PCR
  • 其他

第 7 章：歐洲 PCR 技術市場分析 - 按產品

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率（按產品分類）（%）
  • 試劑及耗材
  • 儀器儀表
  • 軟體和服務

第 8 章：歐洲 PCR 技術市場分析 - 按應用

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率，按應用分類 (%)
  • 基因表現分析
  • 基因定序
  • 基因分型
  • 核酸合成
  • 標準驗證
  • 照護端診斷
  • 環境應用
  • 其他

第 9 章：歐洲 PCR 技術市場分析 - 按最終用戶

  • 概述
  • 2022 年和 2030 年 PCR 技術市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診斷中心
  • 學術界及研究機構
  • 製藥和生物技術公司
  • 其他

第 10 章：歐洲 PCR 技術市場 - 國家分析

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 11 章：PCR 技術市場-產業格局

  • 概述
  • PCR 技術市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Takara Bio Inc
  • Standard Biotools Inc
  • Agilent Technologies Inc
  • Ellume Ltd

第 13 章：附錄

Product Code: BMIRE00030425

The Europe PCR technologies market is expected to grow from US$ 3,880.13 million in 2022 to US$ 7,173.73 million by 2030. It is estimated to record a CAGR of 8.0% from 2022 to 2030.

Increasing Adoption of PCR Techniques in Emerging Countries Drives Europe PCR Technologies Market

Point-of-care (POC) testing presents a significant opportunity for the PCR technology market by expanding its reach and applications. PCR technology, known for its accuracy and sensitivity, is increasingly being adapted for POC testing due to its ability to deliver rapid and reliable results at or near the point of care. As POC testing becomes more prevalent in healthcare settings such as clinics, emergency departments, and decentralized facilities, the demand for PCR platforms and assays tailored for POC applications is expected to rise.

PCR's advantages, including the ability to detect infectious diseases with high specificity and sensitivity, make it well-suited for POC testing, particularly in situations requiring rapid diagnosis and treatment decisions. Additionally, the miniaturization and automation of PCR systems further enable their integration into POC settings, facilitating on-site testing and improving patient care outcomes. As healthcare providers increasingly recognize the value of POC PCR testing in enhancing diagnostic capabilities and patient management, the market for POC PCR technologies is poised for growth and innovation.

Europe PCR Technologies Market Overview

The European PCR technologies market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Funds made available by government and private organizations for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research studies for novel technology-based applications drive the growth of the PCR technologies market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemptions for R&D and new biotech start-ups are expected to favour the European PCR technologies market growth over the forecast period. Germany is one of the largest biotechnology hubs in Europe and worldwide owing to the presence of prominent biotech players, high-tech research labs, and massive funding for conducting research and development activities in the new areas of science and technology. The country has more biotechnology companies than any other European country. The cutting-edge and high-quality research ongoing in Germany creates lucrative opportunities for the already established market for PCR technologies. Individual researchers and academic universities in the country collaborate with international laboratories and institutions to create breakthrough innovations. The rising funds and grants and increasing use of synthetic biology in various application areas are the major factors favoring the growth of the German PCR technologies market. The German government considers the formation of startups to be an essential part of the development of the biotechnology industry in the country. For instance, BIO Deutschland is a sector association of the German biotech industry based in Berlin, with over 330 members that promote and support the development of the industry to help it bloom as a robust economic entity. Similarly, Euronext is another organization that recognizes and utilizes the current momentum of the biotech industry. It thus assists startups by creating jobs, raising funds and investments, and supporting the companies in various other ways.

Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Europe PCR Technologies Market Segmentation

The Europe PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Europe PCR technologies market is categorized into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Europe PCR technologies market in 2022.

In terms of offerings, the Europe PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Europe PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Europe PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Europe PCR technologies market in 2022.

Based on end user, the Europe PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Europe PCR technologies market in 2022.

By country, the Europe PCR technologies market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Europe PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Europe Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Europe PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Europe PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Europe PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Europe PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Europe PCR Technologies Market -Country Analysis

  • 10.1 Europe: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 Europe PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 Germany
        • 10.1.2.1.1 Overview
      • 10.1.2.2 Germany PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 Germany PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 Germany PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 Germany PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 Germany PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 Germany PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 Germany PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 Germany PCR Technologies Market Breakdown by End User
      • 10.1.2.3 United Kingdom
        • 10.1.2.3.1 Overview
      • 10.1.2.4 United Kingdom PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 United Kingdom PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 United Kingdom PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 United Kingdom PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 United Kingdom PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 United Kingdom PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 United Kingdom PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 United Kingdom PCR Technologies Market Breakdown by End User
      • 10.1.2.5 France
        • 10.1.2.5.1 Overview
      • 10.1.2.6 France PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.1 France PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.1.1 France PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.1.2 France PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.1.2.1 France PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.2 France PCR Technologies Market Breakdown by Application
        • 10.1.2.6.3 France PCR Technologies Market Breakdown by End User
      • 10.1.2.7 Italy
        • 10.1.2.7.1 Overview
      • 10.1.2.8 Italy PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.1 Italy PCR Technologies Market Breakdown by Technology
        • 10.1.2.8.2 Italy PCR Technologies Market Breakdown by Offerings
        • 10.1.2.8.2.1 Italy PCR Technologies Market Breakdown by Instruments
        • 10.1.2.8.2.2 Italy PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.8.2.2.1 Italy PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.8.3 Italy PCR Technologies Market Breakdown by Application
        • 10.1.2.8.4 Italy PCR Technologies Market Breakdown by End User
      • 10.1.2.9 Spain
        • 10.1.2.9.1 Overview
      • 10.1.2.10 Spain PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.1 Spain PCR Technologies Market Breakdown by Technology
        • 10.1.2.10.2 Spain PCR Technologies Market Breakdown by Offerings
        • 10.1.2.10.2.1 Spain PCR Technologies Market Breakdown by Instruments
        • 10.1.2.10.2.2 Spain PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.10.2.2.1 Spain PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.10.3 Spain PCR Technologies Market Breakdown by Application
        • 10.1.2.10.4 Spain PCR Technologies Market Breakdown by End User
      • 10.1.2.11 Rest of Europe
        • 10.1.2.11.1 Overview
      • 10.1.2.12 Rest of Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.12.1 Rest of Europe PCR Technologies Market Breakdown by Technology
        • 10.1.2.12.2 Rest of Europe PCR Technologies Market Breakdown by Offerings
        • 10.1.2.12.2.1 Rest of Europe PCR Technologies Market Breakdown by Instruments
        • 10.1.2.12.2.2 Rest of Europe PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.12.2.2.1 Rest of Europe PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.12.3 Rest of Europe PCR Technologies Market Breakdown by Application
        • 10.1.2.12.4 Rest of Europe PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Takara Bio Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Standard Biotools Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Agilent Technologies Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Ellume Ltd
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 31. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 32. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 33. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 34. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 36. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 37. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 38. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 39. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 40. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 41. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 42. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 43. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 44. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 45. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 46. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 47. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 48. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 49. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 50. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 53. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. Europe: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Europe PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 36. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 37. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 38. Growth Strategies in the PCR Technologies Market